{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:24:04Z","timestamp":1789399444239,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014302","name":"Elton John AIDS Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014302","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jhep.2019.09.022","type":"journal-article","created":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T18:20:25Z","timestamp":1570558825000},"page":"67-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Integrating HCV testing with HIV programs improves hepatitis C outcomes in people who inject drugs: A cluster-randomized trial"],"prefix":"10.1016","volume":"72","author":[{"given":"Sunil Suhas","family":"Solomon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suniti","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1157-2931","authenticated-orcid":false,"given":"Allison M.","family":"McFall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aylur K.","family":"Srikrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinita","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muniratnam S.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Laeyendecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D.","family":"Celentano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0410-7051","authenticated-orcid":false,"given":"Syed H.","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santhanam","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canjeevaram K.","family":"Vasudevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanmugam","family":"Saravanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuldeep Singh","family":"Sachdeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti H.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2019.09.022_b0005","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study","volume":"2","author":"Polaris Observatory HCV Collaborators","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2019.09.022_b0010","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1056\/NEJMoa1512610","article-title":"Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection","volume":"373","author":"Feld","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2019.09.022_b0015","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1056\/NEJMoa1512612","article-title":"Sofosbuvir and velpatasvir for HCV genotype 2 and 3 infection","volume":"373","author":"Foster","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jhep.2019.09.022_b0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jhep.2017.03.039","article-title":"Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1\u20136 without cirrhosis","volume":"67","author":"Kwo","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.09.022_b0025","unstructured":"World Health Organization. Global Hepatitis Report, 2017. [cited 2018 October 23]; Available from: http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/255016\/9789241565455-eng.pdf?sequence=1."},{"key":"10.1016\/j.jhep.2019.09.022_b0030","unstructured":"World Health Organization. Guidelines for the Care and Treatment of Persons Diagnosed with Chronic Hepatitis C Virus Infection. 2018 [cited 2018 October 23]; Available from: http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/273174\/9789241550345-eng.pdf?ua=1."},{"key":"10.1016\/j.jhep.2019.09.022_b0035","doi-asserted-by":"crossref","first-page":"e1192","DOI":"10.1016\/S2214-109X(17)30375-3","article-title":"Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review","volume":"5","author":"Degenhardt","year":"2017","journal-title":"Lancet Glob Health"},{"issue":"1","key":"10.1016\/j.jhep.2019.09.022_b0040","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/add.14393","article-title":"Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs","volume":"114","author":"Grebely","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.jhep.2019.09.022_b0045","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(14)71045-X","article-title":"Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study","volume":"15","author":"Solomon","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jhep.2019.09.022_b0050","first-page":"37S","article-title":"Care at the crossroads: navigating the HIV, HCV, and substance abuse syndemic","volume":"31","author":"Reece","year":"2014","journal-title":"Fed Pract"},{"key":"10.1016\/j.jhep.2019.09.022_b0055","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1086\/429502","article-title":"Integrating care for hepatitis C virus (HCV) and primary care for HIV for injection drug users coinfected with HIV and HCV","volume":"41","author":"Kresina","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2019.09.022_b0060","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.drugpo.2007.01.013","article-title":"Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach","volume":"18","author":"Birkhead","year":"2007","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.jhep.2019.09.022_b0065","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1186\/s12913-016-1905-5","article-title":"Design of the Indian NCA study (Indian national collaboration on AIDS): a cluster randomized trial to evaluate the effectiveness of integrated care centers to improve HIV outcomes among men who have sex with men and persons who inject drugs in India","volume":"16","author":"Solomon","year":"2016","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jhep.2019.09.022_b0070","doi-asserted-by":"crossref","first-page":"e283","DOI":"10.1016\/S2352-3018(19)30034-7","article-title":"Integrated HIV testing, prevention, and treatment intervention for key populations in India: a cluster-randomised trial","volume":"6","author":"Solomon","year":"2019","journal-title":"Lancet HIV"},{"key":"10.1016\/j.jhep.2019.09.022_b0075","unstructured":"National AIDS Control Organization (NACO), India. National Technical Guidelines on Antiretroviral Treatment. 2018 [cited 2019 July 16]; Available from: http:\/\/naco.gov.in\/sites\/default\/files\/NACO%20-%20National%20Technical%20Guidelines%20on%20ART_October%202018%20%281%29.pdf."},{"key":"10.1016\/j.jhep.2019.09.022_b0080","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2307\/3096941","article-title":"Respondent-driven sampling: a new approach to the study of hidden populations","volume":"44","author":"Heckathorn","year":"1997","journal-title":"Soc Probl"},{"key":"10.1016\/j.jhep.2019.09.022_b0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1525\/sp.2002.49.1.11","article-title":"Respondent driven sampling II: deriving valid population estimates from chain-referral samples of hidden populations","volume":"49","author":"Heckathorn","year":"2002","journal-title":"Soc Probl"},{"key":"10.1016\/j.jhep.2019.09.022_b0090","first-page":"79","article-title":"Probability based estimation theory for respondent driven sampling","volume":"24","author":"Volz","year":"2008","journal-title":"J Off Stat"},{"key":"10.1016\/j.jhep.2019.09.022_b0095","unstructured":"World Health Organization. Urgent increase in hepatitis testing and treatment needed. 2018. [cited 2019 March 15]; Available from: http:\/\/www.who.int\/hepatitis\/news-events\/hepatitis-testing-treatment-increase\/en\/"},{"key":"10.1016\/j.jhep.2019.09.022_b0100","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S2468-1253(18)30304-2","article-title":"Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis","volume":"3","author":"Hajarizadeh","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.jhep.2019.09.022_b0105","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1111\/jvh.12966","article-title":"The hepatitis C cascade of care in people who inject drugs in Dar es Salaam, Tanzania","volume":"25","author":"Mohamed","year":"2018","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2019.09.022_b0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.drugpo.2018.03.022","article-title":"Hepatitis C virus status awareness and test results confirmation among people who inject drugs in Ukraine","volume":"57","author":"Iakunchykova","year":"2018","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.jhep.2019.09.022_b0115","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugpo.2017.07.002","article-title":"Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: a systematic review","volume":"47","author":"Bajis","year":"2017","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.jhep.2019.09.022_b0120","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.drugpo.2015.05.002","article-title":"Evidence-based interventions to enhance assessment, treatment, and adherence in the chronic hepatitis C care continuum","volume":"26","author":"Meyer","year":"2015","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.jhep.2019.09.022_b0125","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/hep.24656","article-title":"Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations","volume":"55","author":"Martin","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.09.022_b0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002460","article-title":"Respondent-driven sampling for identification of HIV- and HCV-infected people who inject drugs and men who have sex with men in India: a cross-sectional, community-based analysis","volume":"14","author":"Solomon","year":"2017","journal-title":"PLoS Med"},{"key":"10.1016\/j.jhep.2019.09.022_b0135","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1467-9531.2010.01223.x","article-title":"Respondent-driven sampling: an assessment of current methodology","volume":"40","author":"Gile","year":"2010","journal-title":"Sociol Methodol"},{"key":"10.1016\/j.jhep.2019.09.022_b0140","doi-asserted-by":"crossref","first-page":"6743","DOI":"10.1073\/pnas.1000261107","article-title":"Assessing respondent-driven sampling","volume":"107","author":"Goel","year":"2010","journal-title":"PNAS"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827819305884?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827819305884?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:34:40Z","timestamp":1759174480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827819305884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0168827819305884"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2019.09.022","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating HCV testing with HIV programs improves hepatitis C outcomes in people who inject drugs: A cluster-randomized trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2019.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}